NCT06803875: Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 42 planned
- Started
- 31 Jan 2025
- Primary completion
- 31 Dec 2027
- Arms
- Phase 1 Dose Escalation
- Results
- None posted
- 31 Jan 2025: Trial registered
- 31 Jan 2025: Trial started